Latest News and Press Releases

PharmAla releases Q2 financial statements showing increased customer deposits, shipments

PsyCan Excoriates Trudeau Government for Making Assisted Suicide Harder than Psychedelic-Assisted Therapy; Calls on Carney and Poilievre to do better

PharmAla sidesteps tariff risk and expands clinical operations in the United States by contracting with Sharp Clinical Services as distribution partner

PharmAla opens the European Market for MDMA, signs Duchefa Farma as its first national-level distributor for LaNeo MDMA in Europe

Former U.S. Sen. Kyrsten Sinema, Former Ohio Rep. Tim Ryan, Dr. Bessel van der Kolk, Harriet de Wit, Ph.D, Paul Stamets, and other policymakers, researchers, Veterans, therapists, and thought leaders...

PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial

The first-ever dedicated podcast recording area at a Psychedelic Science conference offers podcasters a prime location to capture conversations with scientists, policymakers, and industry leaders...

MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...

PharmAla adds Matthew Azrieli to Advisory Team

PharmAla releases its Q1 financial statements